𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dexamethasone inhibition of confluence-induced apoptosis in human mesenchymal stem cells

✍ Scribed by In-Hwan Song; Arnold I. Caplan; James E. Dennis

Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
221 KB
Volume
27
Category
Article
ISSN
0736-0266

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Human mesenchymal stem cells (MSCs) have been extensively characterized with respect to their in vitro expansion and differentiation potential, especially with respect to osteogenesis. Dexamethasone (Dex) is a well‐known inducer of osteogenic differentiation of MSCs, but little is known about the effect of Dex treatment on apoptosis in MSCs. In this study, apoptosis in MSCs was examined with respect to cell density and Dex supplementation, using DAPI staining and DNA fragmentation ELISA Assay. In MSC cultures initiated at 1.0, 3.0, and 9.0 × 10^3^ cells per cm^2^, it was found that higher MSC density correlated with increased apoptosis and that this apoptotic effect was diminished in cultures containing 100 nM Dex. MSCs and fibroblasts were co‐cultured, along with empty insert controls, and assayed for apoptosis by ELISA and DAPI counts to determine if soluble factors accounted for the cell density‐related apoptosis. No difference was seen between MSCs cultured with inserts containing either MSCs, fibroblasts, or empty control. To determine cell contact effects, BrdU‐labeled MSCs were cultured alone or with unlabeled chondrocytes at 2× and 8× the number of MSCs, with and without Dex, and apoptosis levels quantified. The results showed increased apoptosis at greater cell densities, and that the amount of apoptosis was greatly diminished in cultures containing Dex. These results show that apoptosis in MSCs is cell density‐related, requires direct cell contact, and that Dex treatment reduces or eliminates this density‐related apoptosis. These results may impact how MSCs should be cultured for clinical applications. © 2008 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 27:216–221, 2009

📜 SIMILAR VOLUMES

In vitro dexamethasone pretreatment enha
In vitro dexamethasone pretreatment enhances bone formation of human mesenchymal stem cells in vivo
✍ In-Hwan Song; Arnold I. Caplan; James E. Dennis 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 223 KB

## Abstract Bone grafting is the current standard of care for treatment of fracture nonunions, while alternative strategies such as bone marrow‐derived mesenchymal stem cells are also used. MSCs can be induced towards the osteogenic lineage by in vitro treatment with dexamethasone (dex). This study

Autocrine fibroblast growth factor 18 me
Autocrine fibroblast growth factor 18 mediates dexamethasone-induced osteogenic differentiation of murine mesenchymal stem cells
✍ Zahia Hamidouche; Olivia Fromigué; Ulrike Nuber; Pascal Vaudin; Jean-Christophe 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB 👁 1 views

## Abstract The potential of mesenchymal stem cells (MSC) to differentiate into functional bone forming cells provides an important tool for bone regeneration. The identification of factors capable of promoting osteoblast differentiation in MSCs is therefore critical to enhance the osteogenic poten

In vitro hepatic differentiation of huma
In vitro hepatic differentiation of human mesenchymal stem cells
✍ Kuan-Der Lee; Tom Kwang-Chun Kuo; Jacqueline Whang-Peng; Yu-Fen Chung; Ching-Tai 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 2 views

This study examined whether mesenchymal stem cells (MSCs), which are stem cells originated from embryonic mesoderm, are able to differentiate into functional hepatocyte-like cells in vitro. MSCs were isolated from human bone marrow and umbilical cord blood, and the surface phenotype and the mesoderm

IL-7 inhibits dexamethasone-induced apop
IL-7 inhibits dexamethasone-induced apoptosis via Akt/PKB in mature, peripheral T cells
✍ Hadassah Sade; Apurva Sarin 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB

## Abstract We have investigated the mechanism of IL‐7‐mediated inhibition of dexamethasone‐induced apoptosis in T cells. Broad‐spectrum caspase inhibitors block dexamethasone‐triggered nuclear fragmentation, but not the loss of mitochondrial transmembrane potential or membrane integrity in CD3^+^

Chondrogenesis of human mesenchymal stem
Chondrogenesis of human mesenchymal stem cells encapsulated in alginate beads
✍ Ma, Hsiao-Li ;Hung, Shih-Chieh ;Lin, Shan-Yang ;Chen, Yuh-Lien ;Lo, Wai-Hee 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 361 KB

## Abstract Mesenchymal stem cells (MSCs) have the capacity for self‐renewal and can form bone, fat, and cartilage. Alginate forms a viscous solution when dissolved in 0.9% saline and gels on contact with divalent cations. The viability and phenotype maintenance of chondrocytes in alginate beads ha

The role of noggin in human mesenchymal
The role of noggin in human mesenchymal stem cell differentiation
✍ Leonard Rifas 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 358 KB 👁 2 views

## Abstract Noggin is a secreted protein that inhibits the binding of bone morphogenetic proteins (BMPs) to their cognate receptor. Its role in human mesenchymal stem cell differentiation has not been well studied. Here, we studied the effect of noggin on human mesenchymal stem cell differentiation